RxDoctor Payments Data

Jennifer Sanford, MD

Vascular Surgery · Chesterfield, MONPI 1669798252

Payments from drug & device makers

What this record shows

26 manufacturers reported payments, led by Angiodynamics, Inc. at 42.0% of the total. 2025 is the largest year on record at $3,083, more than ten times the $22 reported in 2020. That places this record below the midpoint for vascular surgery clinicians in MO, where the typical reported total is $6,319.

$4,395in general payments, 2019–2025

Across 56 payments — averaging $78.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$2K
  • Silk Road Medical, Inc.$809
  • Boston Scientific$466
  • Medtronic$192
  • Penumbra, Inc.$146
  • Kestra Medical Technology Services, Inc.$115
  • plus $820 from 20 others

What the payments were for

  • Food & beverage$2,57058%
  • Other$1,82642%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,395 in reported general payments places this provider in the 35th percentile of 92 vascular surgery providers in Missouri.

See all vascular surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$61,506
Medicare patients
423
Services billed
672

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate20$50

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Chesterfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →